Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I–III Triple-Negative Breast Cancer

References

Page 1

	Year	Citations
AJCC Cancer Staging Manual James R. Egner JAMA Surgical OncologyWebsite Uses CookiesMedicineCancer ManagementPatient Safety	2010	6.1K
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard, Clinical Cancer Research	2007	5K
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, New England Journal of Medicine	2004	4.5K
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Journal of Clinical Oncology	2008	2.9K
Metastatic Behavior of Breast Cancer Subtypes Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods, Journal of Clinical Oncology	2010	2.2K
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Priya Rastogi, Stewart Anderson, Harry D. Bear, Journal of Clinical Oncology	2008	1.8K
Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System Clifford A. Hudis, William E. Barlow, Joseph P. Costantino, Journal of Clinical Oncology	2007	860
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients Brigitte Rack, Christian Schindlbeck, Julia Jückstöck, JNCI Journal of the National Cancer Institute	2014	601
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial Judith Hugh, John Hanson, Maggie C.U. Cheang, Journal of Clinical Oncology	2009	533
Circulating tumour cells in non-metastatic breast cancer: a prospective study Anthony Lucci, Carolyn Hall, Ashutosh Lodhi, The Lancet Oncology Breast OncologyMedicinePathologyTumour CellsBreast Cancer	2012	508

Page 1